文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.

作者信息

Davis Hannah E, Assaf Gina S, McCorkell Lisa, Wei Hannah, Low Ryan J, Re'em Yochai, Redfield Signe, Austin Jared P, Akrami Athena

机构信息

Patient-Led Research Collaborative.

Sainsbury Wellcome Centre, University College London, London, United Kingdom.

出版信息

EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. Epub 2021 Jul 15.


DOI:10.1016/j.eclinm.2021.101019
PMID:34308300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8280690/
Abstract

BACKGROUND: A significant number of patients with COVID-19 experience prolonged symptoms, known as Long COVID. Few systematic studies have investigated this population, particularly in outpatient settings. Hence, relatively little is known about symptom makeup and severity, expected clinical course, impact on daily functioning, and return to baseline health. METHODS: We conducted an online survey of people with suspected and confirmed COVID-19, distributed via COVID-19 support groups (e.g. Body Politic, Long COVID Support Group, Long Haul COVID Fighters) and social media (e.g. Twitter, Facebook). Data were collected from September 6, 2020 to November 25, 2020. We analyzed responses from 3762 participants with confirmed (diagnostic/antibody positive; 1020) or suspected (diagnostic/antibody negative or untested; 2742) COVID-19, from 56 countries, with illness lasting over 28 days and onset prior to June 2020. We estimated the prevalence of 203 symptoms in 10 organ systems and traced 66 symptoms over seven months. We measured the impact on life, work, and return to baseline health. FINDINGS: For the majority of respondents (>91%), the time to recovery exceeded 35 weeks. During their illness, participants experienced an average of 55.9+/- 25.5 (mean+/-STD) symptoms, across an average of 9.1 organ systems. The most frequent symptoms after month 6 were fatigue, post-exertional malaise, and cognitive dysfunction. Symptoms varied in their prevalence over time, and we identified three symptom clusters, each with a characteristic temporal profile. 85.9% of participants (95% CI, 84.8% to 87.0%) experienced relapses, primarily triggered by exercise, physical or mental activity, and stress. 86.7% (85.6% to 92.5%) of unrecovered respondents were experiencing fatigue at the time of survey, compared to 44.7% (38.5% to 50.5%) of recovered respondents. 1700 respondents (45.2%) required a reduced work schedule compared to pre-illness, and an additional 839 (22.3%) were not working at the time of survey due to illness. Cognitive dysfunction or memory issues were common across all age groups (~88%). Except for loss of smell and taste, the prevalence and trajectory of all symptoms were similar between groups with confirmed and suspected COVID-19. INTERPRETATION: Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden. FUNDING: All authors contributed to this work in a voluntary capacity. The cost of survey hosting (on Qualtrics) and publication fee was covered by AA's research grant (Wellcome Trust/Gatsby Charity via Sainsbury Wellcome center, UCL).

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/420a6bfea26e/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/c941f85794c9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/3c97a2030ad0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/f1e0d3aba2e6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/47ab9522e908/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/a798094c1e17/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/5da1ef74cd68/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/038b04224533/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/4e8c1f43c3d5/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/461e51a20560/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/6a0f113550ad/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/dd6aaab3f29f/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/420a6bfea26e/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/c941f85794c9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/3c97a2030ad0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/f1e0d3aba2e6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/47ab9522e908/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/a798094c1e17/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/5da1ef74cd68/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/038b04224533/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/4e8c1f43c3d5/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/461e51a20560/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/6a0f113550ad/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/dd6aaab3f29f/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bee/8413245/420a6bfea26e/gr12.jpg

相似文献

[1]
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.

EClinicalMedicine. 2021-8

[2]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[3]
Impact of Long COVID on health and quality of life.

HRB Open Res. 2022-4-22

[4]
Characteristics and impact of Long Covid: Findings from an online survey.

PLoS One. 2022-3-8

[5]
A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.

BMC Infect Dis. 2021-7-13

[6]
Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.

Elife. 2023-2-7

[7]
Investigating the relationship of COVID-19 related stress and media consumption with schizotypy, depression, and anxiety in cross-sectional surveys repeated throughout the pandemic in Germany and the UK.

Elife. 2022-7-4

[8]
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.

Trials. 2021-4-2

[9]
Return-to-work, disabilities and occupational health in the age of COVID-19.

Scand J Work Environ Health. 2021-7-1

[10]
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.

Lancet Respir Med. 2022-9

引用本文的文献

[1]
Exploring the psychological impact of long COVID: symptoms, mechanisms, and treatments.

Front Psychiatry. 2025-8-19

[2]
Post-COVID syndrome in symptomatic COVID-19 patients: a retrospective cohort study.

BMC Infect Dis. 2025-9-3

[3]
Establishing a framework of measurement for use in Long COVID research and practice: protocol for a scoping review involving evidence review and consultation.

BMJ Open. 2025-9-2

[4]
Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster model.

Front Microbiol. 2025-8-14

[5]
Long COVID and chronic fatigue syndrome/myalgic encephalitis share similar pathophysiologic mechanisms of exercise limitation.

Physiol Rep. 2025-9

[6]
Development and internal validation of a prediction model for post-COVID-19 condition 2 years after infection-results of the CORFU study.

Diagn Progn Res. 2025-9-1

[7]
Sleep quality mediates the association between tea consumption and duration of COVID-19-related symptoms in middle-aged and elderly adults (aged 50 and above).

Front Psychiatry. 2025-8-13

[8]
Symptoms and Risk Factors for Long COVID: A Cross-Sectional Study in Primary Care.

J Med Virol. 2025-9

[9]
Do Long COVID and COVID Vaccine Side Effects Share Pathophysiological Picture and Biochemical Pathways?

Int J Mol Sci. 2025-8-15

[10]
Cardio-Pulmonary Features of Long COVID: From Molecular and Histopathological Characteristics to Clinical Implications.

Int J Mol Sci. 2025-8-8

本文引用的文献

[1]
Cognitive deficits in people who have recovered from COVID-19.

EClinicalMedicine. 2021-9

[2]
Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China.

MedComm (2020). 2020-7-2

[3]
Patient-Led Research Collaborative: embedding patients in the Long COVID narrative.

Pain Rep. 2021-4-13

[4]
High-dimensional characterization of post-acute sequelae of COVID-19.

Nature. 2021-6

[5]
Age- and Sex-Associated Variations in the Sensitivity of Serological Tests Among Individuals Infected With SARS-CoV-2.

JAMA Netw Open. 2021-2-1

[6]
Evolution of antibody immunity to SARS-CoV-2.

Nature. 2021-3

[7]
Health Workers' Antibody Levels Wane After SARS-CoV-2 Infection.

JAMA. 2021-1-12

[8]
Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services.

BMC Health Serv Res. 2020-12-20

[9]
False-negative results of initial RT-PCR assays for COVID-19: A systematic review.

PLoS One. 2020

[10]
Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study.

J Infect. 2021-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索